Quantcast

Latest Scleroderma Stories

2011-05-31 12:00:00

Going Social to Spread the Word in 2011 DANVERS, Mass., May 31, 2011 /PRNewswire-USNewswire/ -- June is Scleroderma Awareness Month, and you can become an advocate for the Scleroderma Foundation by raising awareness and teaching others about this chronic, connective tissue disease. This month, join our 23 chapters and more than 145 support groups, as we work to spread the word about this devastating disease. Teaming up with the Scleroderma Foundation in 2011 to spread awareness in the...

2011-05-11 00:35:25

Age and hypertension contribute to coronary calcification -- similar to general population A new study by researchers in Hong Kong suggests that systemic sclerosis is an independent determinant for moderate to severe coronary calcification or atherosclerosis. Conventional cardiovascular risk factors such as age and hypertension predispose patients with systemic sclerosis to plaque build-up in the heart arteries similar to the general population. Details of this study are now available in...

2011-03-28 17:19:49

A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevecâ“ž¢ (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive. "This...

2011-03-18 08:45:00

Vistancia Roadrunners Car Club Holds Breath of Life Car Show for Pulmonary Fibrosis PEORIA, Ariz., March 18, 2011 /PRNewswire-USNewswire/ -- The Vistancia Roadrunners Car Club is driving an effort to raise awareness and funding for a deadly lung disease that threatens one of their members. Elliot Walsey was diagnosed September 2006 with pulmonary fibrosis (PF), a deadly lung disease that has no FDA approved treatment and no cure. The disease, characterized by uncontrolled and lethal...

2011-03-08 15:44:12

Modified-release therapy is well tolerated in clinical trial Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud's phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The double-blind, placebo-controlled trial found that sildenafil was well tolerated with only some subjects experiencing minor or moderate side effects. Full findings are available in the March...

2010-12-08 15:40:00

Pulmonary Fibrosis Claims as Many Lives Each Year as Breast Cancer, Yet Virtually Unknown PEORIA, Ariz., Dec. 8, 2010 /PRNewswire-USNewswire/ -- Elliot Walsey is on a mission to save others who suffer from the disease that will likely kill him. He was diagnosed September 2006 with pulmonary fibrosis (PF), a deadly lung disease that has no FDA approved treatment and no cure. The disease, characterized by uncontrolled and lethal scarring, is virtually unknown to the general population,...

2010-11-08 11:17:42

New research from Georgetown University Medical Center (GUMC) suggests that up to 40 percent of scleroderma patients will not be correctly diagnosed with the disorder using a new automated commercial screening test. The findings of the study will be presented Wednesday, November 10th at the Annual Scientific Meeting of the American College of Rheumatology in Atlanta, Georgia. The American College of Rheumatology recommends immunofluorescence antinuclear antibody (IF-ANA) testing to help...

2010-09-30 12:42:00

DANVERS, Mass., Sept. 30 /PRNewswire-USNewswire/ -- The Scleroderma Foundation applauds the U.S. House of Representatives today for the passage of the Scleroderma Research and Awareness Act (H.R. 2408), introduced last March by Rep. Lois Capps (D-CA) and Rep. Vern Ehlers (R-MI). This bipartisan legislation gives hope to the estimated 300,000 Americans and their families living with this devastating disease. Scleroderma is a chronic and disabling connective tissue disorder resulting from...

2010-08-25 07:00:00

SOUTH SAN FRANCISCO, Calif., Aug. 25 /PRNewswire/ -- Actelion Pharmaceuticals US, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved the brand name VELETRI® for the company's epoprostenol for injection therapy. VELETRI has been commercially available since April 2010 as Epoprostenol for Injection for the treatment of moderate to severe pulmonary arterial hypertension (PAH) and PAH associated with the scleroderma spectrum of disease....

2010-08-18 14:00:00

Golf Tournament to Raise Funds for the Scleroderma Foundation, Southern California Chapter LOS ANGELES, Aug. 18 /PRNewswire-USNewswire/ -- The 2nd Annual "Fight for Lexi" Charity Golf Tournament takes place on Monday, August 23, 2010 at the Dove Canyon County Club. Proceeds from the event will benefit the Scleroderma Foundation/ Southern California Chapter. The event kicks off with a shotgun start at 10:30 a.m., and will be followed by a silent auction and awards dinner. The event...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related